Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 28, 2013; 19(28): 4568-4575
Published online Jul 28, 2013. doi: 10.3748/wjg.v19.i28.4568
Published online Jul 28, 2013. doi: 10.3748/wjg.v19.i28.4568
Figure 1 A considerable difference was found between patients with the Gly/Gly genotype and patients with Gly/Arg or Arg/Arg genotypes after stratified Kaplan-Meier survival analysis.
A: Patients with tumor size ≤ 3 cm; B: Patients with well-differentiated gastric cancer (grades I and II); C: Patients classified as stage T1 or T2; D: Patients with no lymph node involvement; E: Patients at an early clinical stage (I/II).
- Citation: Shen YY, Lu YC, Shen DP, Liu YJ, Su XY, Zhu GS, Yin XL, Ni XZ. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients. World J Gastroenterol 2013; 19(28): 4568-4575
- URL: https://www.wjgnet.com/1007-9327/full/v19/i28/4568.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i28.4568